The specificity of our biomarker signature for the presence and types of intestinal inflammation was examined using two other mouse models of colitis (DSS-treated and TLR5−/− mice) and a model of extra-intestinal inflammation (CAIA). This evidence concerns the gene TLR5 and inflammatory response.